Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.24.1.u1
Segment Information - Schedule of Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 30, 2024
USD ($)
segment
Apr. 01, 2023
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 2  
Segment Reporting Information [Line Items]    
Revenues $ 0 $ 0
Gross profit 0 0
Operating loss (1,806) (1,099)
Depreciation and amortization 639 364
Interest income (expense), net (252) 475
Net income (2,144) 10,085
Discontinued Operations    
Segment Reporting Information [Line Items]    
Revenues 0 3,795
Gross profit 0 (197)
Operating loss 0 14,158
Depreciation and amortization 0 96
Interest income (expense), net 0 181
Net income 0 13,976
Continuing Operations And Discontinued Operations    
Segment Reporting Information [Line Items]    
Revenues 0 3,795
Gross profit 0 (197)
Operating loss (1,806) 13,059
Depreciation and amortization 0 460
Interest income (expense), net 252 (294)
Net income (2,219) 13,087
Biotechnology    
Segment Reporting Information [Line Items]    
Revenues 0 0
Gross profit 0 0
Operating loss (1,806) (1,099)
Depreciation and amortization 0 364
Interest income (expense), net 252 (475)
Net income $ (2,219) $ (889)